Billing and Coding: MolDX: Abbott RealTime IDH1 and IDH2 testing for Acute Myeloid Leukemia (AML) (A55711) - R7 - Effective June 1, 2023

Date Posted: September 25, 2025

This Billing and Coding article has been revised and published for notice under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV).

Effective Date: June 1, 2023

Summary of Article Changes: Under Article Text, added the generic drug name (ivosidenib) in Paragraph 2.

Visit the Noridian Active MolDX Billing and Coding Articles and Educational Articles webpage to view the Billing and Coding article or access it via the CMS MCD.

Last Updated Sep 25 , 2025